Neoral C2 in liver transplant recipients

被引:23
作者
Levy, GA [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Multi Organ Transplant Program, Toronto, ON M5G 1L7, Canada
关键词
D O I
10.1016/S0041-1345(01)02316-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3089 / 3091
页数:3
相关论文
共 6 条
[1]   Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].
Cantarovich, M ;
Barkun, JS ;
Tchervenkov, JI ;
Besner, JG ;
Aspeslet, L ;
Metrakos, P .
TRANSPLANTATION, 1998, 66 (12) :1621-1627
[2]   Immunosuppression in liver transplantation [J].
Cattral, MS ;
Lilly, LB ;
Levy, GA .
SEMINARS IN LIVER DISEASE, 2000, 20 (04) :523-531
[3]  
Levy GA, 2000, TRANSPLANTATION, V69, pS387
[4]   C2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral®1 formulation [J].
Levy, GA .
BIODRUGS, 2001, 15 (05) :279-290
[5]  
Levy GA, 1999, LIVER TRANSPLANT SUR, V5, pS37
[6]  
LEVY GA, 2001, AM J TRANSPLANT, V1, P310